Reexamining paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety.
McClendon
Jennifer
J
D001008:Anxiety Disorders / Q000188:drug therapy* / Q000453:epidemiology; D015982:Bias; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D015897:Comorbidity; D019052:Depression, Postpartum / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use*; D018579:Patient Selection; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy* / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors